to enforce any of our terms and conditions or policies; (f) to protect our operations or those of any of our affiliates and subsidiaries; (g) to protect the rights, privacy, safety or property of Garmin, its affiliates and subsidiaries, you, or others; or (h) to permit us to pursue available remedies or limit the damages that we may sustain.

other offices about your request to convey your concerns or receive information.

offices, factories, mills, shops, machinery, engines, roads, ways, tramways, railways, branches or sidings bridges, reservoirs, watercourses, wharves, electric works and other works and conveniences which may seem calculated directly or indirectly to advance the interests of the Company, and to join with any other person or company in dong any of these things.

behavior of 3D objects and visual environments.

candidate lists; and to maintain accurate statistics on the representation of women at all levels, including an appropriate baseline for five-year projections, against which progress is measured.

photography and other modes of representing words or figures in a visible form, and including where the representation takes the form of electronic display, provided that the same is available for download onto a user’s computer or for printing through conventional small office equipment and, in each case, the Member concerned (where the relevant provision of these Bye-laws require the delivery or service of any document or notice on him in his capacity as Member) has elected or is taken to have agreed for the receipt of the relevant download or notice through electronic means and both the mode of service of the relevant document or notice and the Member’s election or deemed agreement comply with all applicable Statutes, rules and regulations

to be established and maintained and if so the amount thereof so required to be established and maintained, as to the purposes for which the Subscription Right Reserve has been used, as to the extent to which it has been used to make good losses of the Company, as to the additional nominal amount of shares required to be allotted to exercising warrantholders credited as fully paid, and as to any other matter concerning the Subscription Right Reserve shall (in the absence of manifest error) be conclusive and binding upon the Company and all warrantholders and shareholders.

terms thereof, or the termination thereof) of two or more Directors to offices or places of profit with the Company or any other company in which the Company is interested, a separate resolution may be put in relation to each Director and in such case each of the Directors concerned shall be entitled to vote (and be counted in the quorum) in respect of each resolution except where such resolution concerns his own appointment (or the arrangement or variation of the terms thereof, or the termination thereof) and except where, in the case of an office or place of -27profit with any such other company as aforesaid, the other company is a company in which the Director has a material interest.

whether renin-angiotensin system (RAS) antagonists (i.e., angiotensin-converting enzyme [ACE] inhibitors or angiotensin receptor blockers [ARBs] are associated with reduced mortality in heart failure patients with preserved ejection fraction (a measure of how well the left ventricle of the heart pumps with each contraction).